Irreversibility in the post-transfusion phase of hemorrhagic shock.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D001794:Blood Pressure; D001803:Blood Transfusion; D001810:Blood Volume; D002199:Capillary Permeability; D004903:Erythrocyte Aggregation / Q000209:etiology; D005110:Extracellular Space; D006321:Heart / Q000187:drug effects; D006333:Heart Failure / Q000209:etiology; D006801:Humans; D012121:Respiration, Artificial; D012771:Shock, Hemorrhagic / Q000150:complications / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology / Q000628:therapy*; D013268:Stimulation, Chemical; D014662:Vasoconstrictor Agents / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D014662:Vasoconstrictor Agents; D014665:Vasodilator Agents